Solara Active Pharma Sciences stock | 2026 earnings growth & current analysis

Solara Active Pharma...

NSEI:SOLARA

Rp 442,70

Rp-13,95 (-3,05%)

442,70 Rp

Rp-13,95 (-3,05%)

End-of-day quote: 03/30/2026

Solara Active Pharma Sciences Stock Value

Analysts currently rate NSEI:SOLARA as Sell.

Sell

Solara Active Pharma Sciences Company Info

EPS Growth 5Y

-68,17%

Market Cap

Rp22,00 B

Long-Term Debt

Rp1,06 B

Quarterly earnings

N/A

Dividend

Rp0,00

Dividend Yield

0,00%

Founded

2017

Industry

Materials

Country

India

Website

Solara Active Pharma Sciences

ISIN Number

INE624Z01016

Website

http://www.solara.co.in

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

Rp566,00

27.85%

Last Update: 03/30/2026

Analysts: 1

Highest Price Target Rp566,00

Average Price Target Rp566,00

Lowest Price Target Rp566,00

In the last five quarters, Solara Active Pharma Sciences’s Price Target has risen from Rp338,47 to Rp395,00 - a 16,70% increase. One analysts predict that Solara Active Pharma Sciences’s share price will increase in the coming year, reaching Rp566,00. This would represent an increase of 27,85%.

Top growth stocks in the materials sector (5Y.)

What does Solara Active Pharma Sciences do?

Solara Active Pharma Sciences Limited manufactures, produces, processes, formulates, sells, imports, exports, merchandises, distributes, trades in, and deals in active pharmaceutical ingredients (API) in India, Asia Pacific, Europe, North America, South America, and internationally. Business Segments Manufacture and Supply of APIs This segment includes a diverse portfolio of complex molecules catering to various therapeutic categories, such as cardiology, psychiatry, and dermatology. Interme...

Business Segments

Manufacture and Supply of APIs

This segment includes a diverse portfolio of complex molecules catering to various therapeutic categories, such as cardiology, psychiatry, and dermatology.

Intermediates

This segment provides comprehensive solutions for its clients. The diversification of its product offerings ensures a broad customer base within the pharmaceutical sector, enabling the company to navigate market fluctuations more adeptly. By fostering long-term partnerships with clients and enhancing product development timelines, the company seeks to maintain its competitive edge, ensuring sustained growth.

Business Strategy

The company's business strategy is centered upon innovation and quality assurance. The company recognizes that the pharmaceutical landscape is constantly evolving, and as such, it emphasizes a proactive approach to adapt to market dynamics. The company's investment in research and development is a foundational pillar of its strategy, aimed at expanding the product portfolio and enhancing the technological capabilities essential for developing complex APIs.

The company further adopts a customer-centric approach by tailoring solutions to meet the specific needs of its clientele. Engaging with customers through regular consultations and feedback mechanisms facilitates the development of customized products, enhancing client satisfaction and fostering long-term partnerships.

Additionally, the company is focused on expanding its geographical reach, targeting emerging markets alongside its established presence in developed markets. This geographical diversification serves to mitigate risks associated with market volatility and to capitalize on opportunities presented by growing demand for pharmaceuticals globally. The integration of advanced technologies and digital solutions within the company’s operational framework also plays a crucial role in driving efficiency and reducing time-to-market.

Products and Services

The company offers a comprehensive range of products and services within the pharmaceutical sector.

Active Pharmaceutical Ingredients (APIs)

The company offers API that are critical for formulation in various therapeutic segments, including limited to cardiology, gynecology, and neurology. The company's product line includes complex molecules that often require sophisticated manufacturing processes, showcasing its capabilities and expertise.

Intermediates

The company offers intermediates that serve as key building blocks for pharmaceutical formulations. This breadth of products enables the company to cater to the diverse needs of its clients, from large multinational corporations to smaller firms.

Services

The company encompass custom synthesis, where the company works closely with clients to develop specialized formulations that meet specific requirements. This bespoke service model reflects the company’s commitment to delivering tailored solutions that align with customer needs and accelerates product development timelines.

Geographical Markets Served

The company operates in a diverse range of geographical markets, strategically positioned to serve both domestic and international clients. Its market reach spans across North America, Europe, Latin America, and parts of Asia.

Seasonality

The company experiences certain seasonal variations that impact its operational activities and sales dynamics. Demand for pharmaceuticals may fluctuate based on various factors, including regulatory approvals, healthcare funding, and regional health initiatives. Additionally, the company's product launches may also be timed to coincide with market trends or health campaigns that influence purchasing decisions. Seasonal factors may affect production schedules, inventory management, and distribution strategies, necessitating agile responses to these variations.

Customers

The company serves a diverse array of customers within the pharmaceutical sector. The company's clientele includes multinational pharmaceutical corporations, generic drug manufacturers, and smaller biotechnology firms.

History

The company was incorporated in 2017. The company was formerly known as SSL Pharma Sciences Limited and changed its name to Solara Active Pharma Sciences Limited in March 2017.

New support ticket

Explore

Solara Active Pharma Sciences Stock Value

Solara Active Pharma Sciences Company Info

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

Top growth stocks in the materials sector (5Y.)

What does Solara Active Pharma Sciences do?

Offer & Services

Service & Collaboration

Company & Legal

New support ticket

Explore

Solara Active Pharma Sciences Stock Value

Solara Active Pharma Sciences Company Info

Analyst Price Target The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

Top growth stocks in the materials sector (5Y.)

What does Solara Active Pharma Sciences do?

Offer & Services

Service & Collaboration

Company & Legal

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.